Real-World study tracks Epidyolex's Long-Term impact on seizures
NCT ID NCT05772429
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 158 people in France who are prescribed Epidyolex (a cannabidiol-based medicine) for seizures as part of their normal care. Researchers will track how long people stay on the treatment, side effects, seizure frequency, and changes in daily functioning and quality of life over two years. The goal is to understand how well Epidyolex works in real-world settings outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Epidyolex (cannabidiol oral solution)
What this could lead to
If successful, this study could confirm how well Epidyolex works in everyday practice and help doctors better manage seizures long-term.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new treatment, only monitors existing use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEIZURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - Marseille - service adulte
Marseille, 13005, France
-
APHP Kremlin Bicetre - service enfant
Le Kremlin-Bicêtre, 94270, France
-
APHP Necker - service enfant
Paris, 75743, France
-
APHP Pitié Salpetriere- service adulte
Paris, 75013, France
-
APHP Robert Debré - service enfant
Paris, 75019, France
-
CHU Amiens-service adulte
Amiens, 80054, France
-
CHU Amiens-service enfant
Amiens, 80054, France
-
CHU Angers - service adulte
Angers, 49100, France
-
CHU Angers - service enfant
Angers, 49100, France
-
CHU Bordeaux - service adulte
Bordeaux, 33000, France
-
CHU Bordeaux,neuropédiatrie
Bordeaux, 33000, France
-
CHU Dijon - service neurophysiologie clinique
Dijon, 21000, France
-
CHU Grenoble - service adulte
Grenoble, 38700, France
-
CHU Grenoble - service enfant
Grenoble, 38700, France
-
CHU Lille - service enfant
Lille, 59037, France
-
CHU Nancy - service adulte
Nancy, 54000, France
-
CHU Nancy - service enfant
Nancy, 54000, France
-
CHU Rennes - service adulte
Rennes, 35000, France
-
CHU Rennes - service enfant
Rennes, 35200, France
-
CHU Strasbourg - service enfant
Strasbourg, 67200, France
-
CHU Toulouse - service adulte
Toulouse, 31059, France
-
CHU Toulouse - service enfant
Toulouse, 31059, France
-
GH Est - Hôpital Femme Mère Enfant
Bron, 69500, France
-
HCL - Lyon - service adulte
Bron, 69677, France
-
Hôpital Bretonneau - service adulte
Tours, 37000, France
-
Hôpital Clocheville - service enfant
Tours, 37044, France
-
Hôpital Salengro - service adulte
Lille, 59037, France
-
Hôpital de Hautepierre - service adulte
Strasbourg, 67200, France
-
Hôpital de la Timone - service enfant
Marseille, 13005, France